Skip to main content
. 2015 Oct;75(10):1043–1050. doi: 10.1055/s-0035-1558054

Table 1 Follow-up of hydatidiform moles modified from Ka Yu Tse et al. (Obstetrics, Gynaecology and Reproductive Medicine, 2015 39).

CHM PHM
Duration of serum/urine β-hCG controls 1 year 3–6 months
Frequency of β-hCG measurement weekly until 3 × negative, then monthly weekly until 2–3 × negative, then monthly
Prophylactic chemotherapy no no
Risk of subsequent GTD 1–2 % following one previous mole15–18 % following two previous moles
Chance for GTN 15–20 % 0.5–2 %